Globus Medical, Inc. Class A Common Stock (GMED)
R&D Expenses
$184.82M
TTM · Period ending: · USD
GMED R&D Expenses
Latest reported$184.82Mperiod ending
Latest reported$184.82Mperiod ending
GMED R&D Expenses ($20.52M → $184.82M)
Annual R&D Expenses
High-resolution chart · PNG
GMED r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 185,000,000 | |
| 163,754,000 | |
| 124,010,000 | |
| 73,015,000 | |
| 97,346,000 | |
| 84,519,000 | |
| 60,073,000 | |
| 55,496,000 | |
| 43,679,000 | |
| 44,532,000 | |
| 36,312,000 | |
| 31,166,000 | |
| 26,870,000 | |
| 27,926,000 | |
| 23,464,000 | |
| 21,309,000 | |
| 20,521,000 |